Effect Effect of Implementing Safety Recommendation on Outcomes of Patients Receiving Radioiodine Therapy
Radiation safety recommendations are an integral part of targeted radionuclide therapy. The current study aimed to assessment of knowledge for patients receiving radioactive iodine therapy, formulate radiation safety recommendations and evaluate the effect of safety recommendations on outcomes of patients receiving radioiodine therapy.
Design; Quasi-experimental study was used in this study.
Setting: The study was carried out in the Nuclear Medicine Department and Oncology Department at South Egypt Cancer Institute and Assiut University Hospital.
Sample: Sample of (30) adult patients from both sex were participated at this study; their ages ranged from (18 – 65) years, having thyroid disorder not pregnant or lactating.
Tools: (1) Patient interview assessment questionnaire sheet.
Tool (2): Patient knowledge assessment questionnaire sheet (pre/post).
Result: There was statistically significant difference between pre and post implementation of safety recommendations as regard total scores of knowledge and patient outcomes.
Conclusion: Safety recommendations are effective in improves patient outcomes (minimize radiation hazard and improve knowledge for patients receiving radioiodine therapy.
Recommendations: Telenursing strategy application for patients' compliance with radiation safety recommendations after discharge.
Backman L., Qiu C., and Winblad B., (2001): The influence of education on clinically diagnosed demention: incidence and mortality data from the Kung sholmem project. Arch neural journal, Vol. (58), no. (13), p.P 2034- 2039.
Cynthia Gj.,(2000): Nuclear Material Safety and Safeguards
Nuclear Regulatory Commission Nuclear Regulatory Research, The Code of Federal Regulations; Nuclear Regulatory Commission P.P 1-49
Donald A M., David R. ,Brill MD., David V. Becker, MD.,Susan EM., Clarke, MD., Edward B. Silberstein, MD., Henry D. Royal, MD. Helena R. and Balon, MD., (2002): Procedure Guideline for Therapy of Thyroid Disease with 131I J Nucl Med Vol. 43, No (6), P .P 856–861.
Greenlee C. and Kloos RT. (2011): Thyroid and Safety recommendations for 131I vary among health care providers, Endocrine Today, Vol. 21, No (4), P.P 151-160.
James C S., John F., Iain R.M., Lawrence T D., James RH., James D., Charlotte H. , David R., Michael JT., Jason A W., Ernest A., Anca M. A., , Mira M., and Carol G., ( 2011): Radiation Safety in the Treatment of Patients with Thyroid Diseases by Radioiodine 131I, Practice, Recommendations of the American Thyroid Association,Vol. 21, No. (4), P.P 335-339.
Jonsson, H. and Mattsson, S. (2004): Excess radiation absorbed doses from non-optimize radioiodine treatment of hyperthyroidism. Radiate, Dosimetry, Vol. 108, No (2) P.P 107-114.
Jubbin J., Charles S. Thomas V. Paul T., Regi O. and Mandalam S. , (2015): impact of dietary iodine restriction in short term development of hypothyroidism following fixed dose radioactive iodine therapy for Graves’ disease , Indian J Endocrinol, Metab ,Vol. 19, No(1) P.P 60–65.
Kloos RT (2011): Survey of radioiodine therapy safety practices highlights the need for user-friendly recommendations.
(Editorial) Thyroid .Vol.21, No (2), P.P47–48.
Krassas GE, and Perros P. (2003): Thyroid disease and male reproductive function. J Endocrinol Investig. Vol.26, No(4), P.P 372–80
Makris, K., Andra, S., Jia, A., Herrick, L., Christophi, C., Snyder, S., and Hauser R., (2013): Association between water consumption from polycarbonate containers and bisphenol , intake during harsh environmental conditions in summer. Environmental Science Technology, Vol. 47, no (7), P.P 3333-3343.
Marriott CJ, Webber CE, and Gulenchyn KY (2007): Radiation exposure for ‘‘care-givers’’ during high-dose outpatient radioiodine therapy. Radiat Prot Dosim Vol.123,No(1),P.P 62–67
Meier DA., Brill DR., Becker DV., Clarke SE., Silberstein EB., and Royal HD., (2002):Procedure Guidelines for Therapy of thyroid Disease with Iodine-131 (Sodium Iodide) J Nucl Med. Vol,43No (6), P.P 856–861
Michael A. and Thompson (2001): Radiation Safety Precautions in the Management of the Hospitalized 131I Therapy Patient J. Nucl. Med. Technol. June 1, Vol. 29, no. (2), P.P 61-66.
Miller, M., Crofton, K., Rice, D., and Zoeller, R., (2009): Thyroid-disrupting chemicals: Interpreting upstream biomarkers of adverse outcomes. Environmental Health Perspectives, Vol. 117, no (7), P.P 1033–1041.
Pelletier-G M., Martineau PK., Ran H., Matthew Z., and Lionel S., (2018): "Reproducibility of radioactive iodine uptake measurements". Journal of Applied Clinical Medical Physics. Vol.19 No (1):P.P 239–242.
Ralph M., Frieda S., Annel M C., Diego R., and Brenda G T., (2016): Evaluation of Household Radiation Exposure and Safety after Ambulatory Radioiodine Ablation Therapy. Journal Of Thyroid Cancer, Vol.1, no. (1):P.P35-41.
Reinhardt MJ., Brink I., Joe AY., Mallek D., Ezziddin S., Palmedo H., and Krause TM., (2002): Radioiodine therapy in Graves’ disease based on tissue-absorbed dose calculations: effect of pre-treatment volume on clinical outcome. Eur J Nucl Med Vol.29, No (9), P.P1118–1124
Rosemary p., (2005): Nursing the surgical patient, chapter (12), second ed., Elsevier Company, London, P.P 221:231.
Saccani M., Morganti S., Milli B., Ugolotti D., and Prampolini R.,(2005): Thyroid Gland Disorders ,Journal of endo-crinological investigation, Vol.28, No (11), P P. 101:104.
Sawka AM., Lea J, Alsheri B, Straus S, Tsang RW., Brierley JD., Thabane L., Rotstein L., Gafni A., Ezzat S., and Goldstein DP., (2008): A systemic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors. Clin Endocrinol, Vol.68, No (4) P.P 610–617.
Shackett P. (2009): Nuclear medicine technology: procedures and quick reference. Philadelphia, Wolters, Kluwer/Lippincott Williams & Wilkins, 2nd edition, p.p. 492–493.
Siegel JA, Marcus CS, and Stabin MG (2007): Licensee over-reliance on conservatisms in NRC guidance regarding the release of patients treated with 131-I. Health Physic, Vol. 93, No (6),P.P 667–677.
Thompson MA. (2001): Radiation safety precautions in the management of the hospitalized 131I therapy patient. J Nucl Med Technol. Jun; Vol.29 No (2), P.P61-66, P.P 74-75.
Wazir M., Faaruq, S., Hussain A., Basim K M., and Shahab F (2009 ) : radio-active iodine therapy for hyperthyroidism treatment protocol ,Handbook of Hyperthyroidism, Etiology, Editor; Lionel Mertens and Jeremy Bogaert , Nova Science Publishers, Inc.
Chapter 15 ,P.P 1-49
Weetman A P., (2000): Graves’ Disease, thyroid hormone Production, New Engl J Med. Vol.343, No (17),P.P 1236–1248
Williamson MS, Dauer LT, St. Germain J, and Strauss HW (2007): Tl-201 stress tests and homeland security. J Nucl Cardiol
Vol.14, No (4), P.P582–588.
Winslow E H., (2004): Patient Education Materials. American Journal of Nursing, Vol. (102), No. (17), p.p: 33-38.
Ying L, Kay C, A .Yupin A. ,Xin-Y. and PingJ.( 2014): Patient outcomes in the field of nursing: A concept analysis Vol. 1, No(1), P.P 69-74
Copyright (c) 2019 IJRDO - Journal of Health Sciences and Nursing (ISSN: 2456-298X)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Author(s) and co-author(s) jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere. Author(s) agree to the terms that the IJRDO Journal will have the full right to remove the published article on any misconduct found in the published article.